Nello Mainolfi, CEO: Kymera Therapeutics KYMR Planned sale · Filed 25/10/29

Trade details

Type: Planned sale notice
Stock: Kymera Therapeutics KYMR
Person: Nello MainolfiCEO
Planned sale date: 25/10/29
Filed: 25/10/29

More to sell after $1.5M in 3 months

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/29~25/11/28

Nello Mainolfi's recent trades

Nello MainolfiCEO
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$6M
50,000 sh
$6M
Filed 07/07
Traded 07/07
Nello MainolfiCEO
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$9.1M
80,000 sh
$9.1M
Filed 07/02
Traded 07/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$1.4M
17,005 sh
$1.4M
Filed 04/29
Traded 04/29
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$985.2K
12,059 sh
$985.2K
Filed 04/29
Traded 04/29
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$77.2K
936 sh
$77.2K
Filed 04/29
Traded 04/29

Nello Mainolfi, CEO — plans to sell 30,000 sh of Kymera Therapeutics KYMR · $1.9M · around 10/29 · 10b5-1 plan | Whalegun